SHR-A1909
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 29, 2025
A Study of SHR-A1909 in Subjects With Advanced Malignant Tumors
(clinicaltrials.gov)
- P1 | N=12 | Completed | Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd. | Recruiting ➔ Completed | N=100 ➔ 12
Enrollment change • Trial completion • Oncology • Solid Tumor
January 13, 2022
A Study of SHR-A1909 in Subjects With Advanced Malignant Tumors
(clinicaltrials.gov)
- P1; N=100; Recruiting; Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Oncology
1 to 2
Of
2
Go to page
1